Literature DB >> 8302951

Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator.

Y S Yun1, Y S Lee, S K Jo, I S Jung.   

Abstract

The water extract of Panax ginseng was fractionated by its solubility in ethanol and then the ethanol-insoluble fraction was tested for immunomodulatory activity. The ethanol-insoluble fraction of ginseng (Fr. 3) proliferated splenocytes and generated activated killer cells in vitro. These activated killer cells killed both NK cell sensitive and insensitive tumor target cells without MHC-restriction. Activation of splenocytes by ginseng was mediated through the endogenously produced IL-2. To investigate the effects of Fr.3 on the autochthonous neoplasm, a single subcutaneous injection of 0.5 mg of benzo[a]pyrene (BP) was given within 24 hours after birth of male N: GP(S) mice, and Fr.3 was administered in drinking water at a concentration of 2 mg/ml, 1 mg/ml, or 0.5 mg/ml for 6 weeks after weaning. The treatment with Fr. 3 significantly inhibited lung tumor incidence (P < 0.05) compared with the BP alone group at a concentration of 2 mg/ml or 1 mg/ml in drinking water at the 9th week after BP treatment. These results suggest that the ethanol-insoluble fraction of ginseng shows antitumor effects as an immunomodulator.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302951     DOI: 10.1055/s-2006-959752

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  pS2 expression induced by American ginseng in MCF-7 breast cancer cells.

Authors:  R B Duda; B Taback; B Kessel; D D Dooley; H Yang; J Marchiori; B M Slomovic; J G Alvarez
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

Review 2.  Medicinal Plants and Other Living Organisms with Antitumor Potential against Lung Cancer.

Authors:  Luara de Sousa Monteiro; Katherine Xavier Bastos; José Maria Barbosa-Filho; Petrônio Filgueiras de Athayde-Filho; Margareth de Fátima Formiga Melo Diniz; Marianna Vieira Sobral
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

3.  A 14-week randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy and safety of ginseng polysaccharide (Y-75).

Authors:  Young-Jin Cho; Hyeog-Jin Son; Kyung-Soo Kim
Journal:  J Transl Med       Date:  2014-10-09       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.